Cargando…
MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia
Neointima formation is the major reason for vein graft failure. However, the underlying mechanism is unclear. The aim of this study was to determine the role of miR-26a in the development of neointimal hyperplasia of autogenous vein grafts. Using autologous jugular vein grafts in the rat carotid art...
Autores principales: | Tan, Juanjuan, Yang, Liguo, Liu, Cuicui, Yan, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399463/ https://www.ncbi.nlm.nih.gov/pubmed/28429763 http://dx.doi.org/10.1038/srep46602 |
Ejemplares similares
-
Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation
por: Wu, Wen, et al.
Publicado: (2019) -
Adenovirus-Mediated Gene Transfer of microRNA-21 Sponge Inhibits Neointimal Hyperplasia in Rat Vein Grafts
por: Wang, Xiao-Wen, et al.
Publicado: (2017) -
Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia
por: Ko, Dai Sik, et al.
Publicado: (2022) -
Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts
por: Zou, Junjie, et al.
Publicado: (2011) -
Patient-Specific, Multi-Scale Modeling of Neointimal Hyperplasia in Vein Grafts
por: Donadoni, Francesca, et al.
Publicado: (2017)